Boston Scientific Corporation (BSX) : Money flow in the Boston Scientific Corporation (BSX) stock was negative (5.02 million) on Wednesday, which shows that the investors used the strength in the stock price to reduce their holdings. The total traded value on upticks was $15.62 million, compared to $20.64 million on downticks. The total uptick to downtick ratio was 0.76, indicating the underlying weakness in the stock. Even in block trades, money flow was negative ($5.92 million), indicating selling on the strength. The transaction value during uptick in block trades was $3.54 million. Downtick transaction value in block trades amounted to $9.47 million, indicating persistent selling. The uptick to downtick ratio was 0.37. Boston Scientific Corporation (BSX) traded $0.03 higher at $23.75 gaining 0.13% over the previous days close.
Shares of Boston Scientific Corporation appreciated by 0.08% during the last five trading days but lost 2.26% on a 4-week basis. Boston Scientific Corporation is up 3.13% in the last 3-month period. Year-to-Date the stock performance stands at 28.8%.
Boston Scientific Corporation (BSX) : 20 analysts are covering Boston Scientific Corporation (BSX) and their average rating on the stock is 1.63, which is read as a Buy. 12 equity analysts believe that the stock has a bright future and the price doesnt capture all of its upside, hence they rate the stock as a Strong Buy. Boston Scientific Corporation (BSX) also receives 3 more Buy recommendations from analysts who believe that the stock will do well going forward. A Zacks Investment Research rank of 3, which recommends a Hold affirms that they expect a large upside in the stock from the current levels. A total of 5 brokerage firms believe that the stock is fairly valued, hence they advise a Hold on the stock.
Boston Scientific Corporation (NYSE:BSX): The stock opened at $23.73 and touched an intraday high of $23.77 on Wednesday. During the day, the stock corrected to an intraday low of $23.565, however, the bulls stepped in and pushed the price higher to close in the green at $23.75 with a gain of 0.13% for the day. The total traded volume for the day was 6,611,798. The stock had closed at $23.72 in the previous trading session.
Boston Scientific Corporation develops, manufactures and markets medical devices. The Company offers its products by seven core businesses: Interventional Cardiology, which includes Drug-Eluting Coronary Stent Systems, Intravascular Imaging devised and Coronary Technology products, such as guide wires, guide catheters, and balloon catheters, among others; Peripheral Interventions (PI), which include stents, balloon catheters, wires, peripheral embolization devices and vena cava filters; Cardiac Rhythm Management (CRM), which include implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities; Electrophysiology (EP), which include steerable RF ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories; Endoscopy, which includes Spyglass System, WallFlex Colonic Stents, Resolution Clip, and Expect Aspiration Needle, among others; Urology and Womens Health, and Neuromodulation.